Defining and predicting indolent and low risk prostate cancer

Publication year: 2011 Source: Critical Reviews in Oncology/Hematology, Available online 26 October 2011 Chris H. Bangma, Monique J. Roobol The early detection of asymptomatic prostate cancer has led to the increased incidence of tumours that are unlikely to become symptomatic during life, so called indolent cancers. The prediction of low risk and indolent prostate cancer is needed to avoid overtreatment by unnecessary invasive therapies, and select men for active surveillance

Publication year: 2011 Source: Critical Reviews in Oncology/Hematology, Available online 26 October 2011 Chris H. Bangma, Monique J. Roobol The early detection of asymptomatic prostate cancer has led to the increased incidence of tumours that are unlikely to become symptomatic during life, so called indolent cancers. The prediction of low risk and indolent prostate cancer is needed to avoid overtreatment by unnecessary invasive therapies, and select men for active surveillance

Read More:
Defining and predicting indolent and low risk prostate cancer

Related posts:

  1. Prostate metastatic bone cancer in an Egyptian Ptolemaic mummy, a proposed radiological diagnosis
  2. Cancer prevalence and mortality in centenarians: A systematic review
  3. Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis
  4. DNA replication fidelity and cancer
  5. Role of Telomeres and Telomerase in Cancer
  6. Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research
  7. Adjuvant early breast cancer systemic therapies according to daily used technologies
  8. TheMYCNoncogene and differentiation in neuroblastoma
  9. Autophagy in cancer: having your cake and eating it.
  10. Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations